Open AccessDrug of Choice in the Management of Hypertension in Diabetes and Diabetic Nephropathy: Angiotensin‐Converting Enzyme Inhibitors
Author(s) -
Ritz Eberhard
Publication year - 2011
Publication title -
the journal of clinical hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.909
H-Index - 67
eISSN - 1751-7176
pISSN - 1524-6175
DOI - 10.1111/j.1751-7176.2011.00448.x
Subject(s) - medicine , diabetes mellitus , blood pressure , diabetic nephropathy , nephropathy , renin–angiotensin system , disease , kidney disease , angiotensin converting enzyme , cardiology , endocrinology
Hypertension is common in patients with diabetes mellitus and is a main cause of renal and cardiovascular complications. There has been recent controversy on what should be considered the optimal blood pressure goal and the optimal antihypertensive agent. It has become apparent that one blood pressure does not fit all in diabetic patients. Major confounders are preexisting cardiovascular disease and presence or absence of proteinuric kidney disease. In proteinuric diabetic nephropathy, renin‐angiotensin system blockade is clearly indicated, but monotherapy is practically always insufficient to achieve target blood pressure values. J Clin Hypertens (Greenwich) . 2011;13:285–289. © 2011 Wiley Periodicals, Inc.